These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 24415778)
1. KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma. Malaisé M; Rovira J; Renner P; Eggenhofer E; Sabet-Baktach M; Lantow M; Lang SA; Koehl GE; Farkas SA; Loss M; Agha A; Campistol JM; Schlitt HJ; Geissler EK; Kroemer A J Immunol; 2014 Feb; 192(4):1954-61. PubMed ID: 24415778 [TBL] [Abstract][Full Text] [Related]
2. CD27low natural killer cells prolong allograft survival in mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner. Lantow M; Eggenhofer E; Sabet-Baktach M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A Transplantation; 2015 Feb; 99(2):391-9. PubMed ID: 25606781 [TBL] [Abstract][Full Text] [Related]
3. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses. Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394 [TBL] [Abstract][Full Text] [Related]
4. Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice. Sabet-Baktach M; Eggenhofer E; Rovira J; Renner P; Lantow M; Farkas SA; Malaisé M; Edtinger K; Shaotang Z; Koehl GE; Dahlke MH; Schlitt HJ; Geissler EK; Kroemer A J Immunol; 2013 Oct; 191(8):4440-6. PubMed ID: 24058178 [TBL] [Abstract][Full Text] [Related]
5. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells. Tayade C; Fang Y; Black GP; V A P; Erlebacher A; Croy BA J Leukoc Biol; 2005 Dec; 78(6):1347-55. PubMed ID: 16204645 [TBL] [Abstract][Full Text] [Related]
6. The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo. Gründemann C; Schwartzkopff S; Koschella M; Schweier O; Peters C; Voehringer D; Pircher H Eur J Immunol; 2010 May; 40(5):1303-14. PubMed ID: 20201037 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells. Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813 [TBL] [Abstract][Full Text] [Related]
9. T-bet plays a key role in NK-mediated control of melanoma metastatic disease. Werneck MB; Lugo-Villarino G; Hwang ES; Cantor H; Glimcher LH J Immunol; 2008 Jun; 180(12):8004-10. PubMed ID: 18523263 [TBL] [Abstract][Full Text] [Related]
10. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents. Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033 [TBL] [Abstract][Full Text] [Related]
11. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Kelly JM; Darcy PK; Markby JL; Godfrey DI; Takeda K; Yagita H; Smyth MJ Nat Immunol; 2002 Jan; 3(1):83-90. PubMed ID: 11743585 [TBL] [Abstract][Full Text] [Related]
12. Functional plasticity and robustness are essential characteristics of biological systems: lessons learned from KLRG1-deficient mice. Jonjic S Eur J Immunol; 2010 May; 40(5):1241-3. PubMed ID: 20373518 [TBL] [Abstract][Full Text] [Related]
13. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related]
14. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491 [TBL] [Abstract][Full Text] [Related]
15. Chronic alcohol consumption inhibits peripheral NK cell development and maturation by decreasing the availability of IL-15. Zhang F; Little A; Zhang H J Leukoc Biol; 2017 Apr; 101(4):1015-1027. PubMed ID: 27837016 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cell depletion confounds the antitumor mechanism of endogenous IL-12 overexpression. Miller G; Bleier JI; Antonescu C; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP Int J Cancer; 2004 Jun; 110(3):395-402. PubMed ID: 15095305 [TBL] [Abstract][Full Text] [Related]
17. Osteopontin promotes the development of natural killer cells from hematopoietic stem cells. Chung JW; Kim MS; Piao ZH; Jeong M; Yoon SR; Shin N; Kim SY; Hwang ES; Yang Y; Lee YH; Kim YS; Choi I Stem Cells; 2008 Aug; 26(8):2114-23. PubMed ID: 18535152 [TBL] [Abstract][Full Text] [Related]
18. Role of Th1/Th17 balance regulated by T-bet in a mouse model of Mycobacterium avium complex disease. Matsuyama M; Ishii Y; Yageta Y; Ohtsuka S; Ano S; Matsuno Y; Morishima Y; Yoh K; Takahashi S; Ogawa K; Hogaboam CM; Hizawa N J Immunol; 2014 Feb; 192(4):1707-17. PubMed ID: 24446514 [TBL] [Abstract][Full Text] [Related]
19. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer. Rodolfo M; Zilocchi C; Accornero P; Cappetti B; Arioli I; Colombo MP J Immunol; 1999 Aug; 163(4):1923-8. PubMed ID: 10438927 [TBL] [Abstract][Full Text] [Related]
20. Monocytes control natural killer cell differentiation to effector phenotypes. Soderquest K; Powell N; Luci C; van Rooijen N; Hidalgo A; Geissmann F; Walzer T; Lord GM; Martín-Fontecha A Blood; 2011 Apr; 117(17):4511-8. PubMed ID: 21389319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]